Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Couldn’t agree with you more PW! Interesting to see more news media coverage on these talking points.
The FDA never tested the current mRNA vaccine. They just tweaked it for the current variant with no clinical trials. Even though it has been proven that their vaccine causes heart attacks and other heart issues with the young. Very sloppy and unprofessional IMO. Yet they will raise the bar of standard off-the-charts for Revives drug. The FDA is corrupt and they are bought off by Big Pharm. Until Congress gets involved, it will be more of the same for decades to come. We might need a hard ass like Trump to fix this. For better or worse.
Florida State Surgeon General Dr. Joseph Ladapo is calling on healthcare providers to halt the use of COVID-19 mRNA vaccines, citing purported health risks labeled "misinformation" by federal officials.
Its all about not letting these muppets have absolute control over the narrative.
Bashing has become a lost art really these days i must admit with the lot that runs around from board to board spewing utter shite.
Still riding those freebies and gained a bit more doing the same at these levels but nothing to harp about really.
Been taking a break from all their buffoonery over the past couple months in preparation of 2024.
Hoping ole mikey can seal something re an application for buccy.
Now that would be a royal new years present innit!!!
Wishing everyone a Happy New Year.......cheers!
And yet you're still here!
Yes that what Michael Frank does. He raises cash via dilution and spends shareholder money on himself
Remember the offering he did last January and 6 weeks later investors were down 90%
Thank goodness Canadians took the brunt of that debacle
Question my man. Do you hold those who post positively about Revive to the same standard?
I rest my case.
Anyone who posts negatively about Revive is welcome provided it is factually backed up.
I call out cunts like you when they attempt to toxically belittle a stock which many investors and their families are weighted in.
We pity you and your desperate need for attention.
I always thought you were a reasonable person, but you’re actually quite emotional.
Michaels money train rolls on.
Shooting the messenger. Is that all you got? Truth hurts when you live in a cult. Classic.
Yeah unbelievable isn’t it. “All in” and openly proud of it. “Holding until I’m up or die” and completely clueless. Ignorance got them here and ignorance will get them what they deserve. At least they’re consistent.
Wow. The fraud continues
Revive Therapeutics Announces Results of Annual General and Special Meeting of Shareholders
https://financialpost.com/globe-newswire/revive-therapeutics-announces-results-of-annual-general-and-special-meeting-of-shareholders
TORONTO, Dec. 20, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the results of its annual general and special meeting of shareholders held Tuesday, December 19, 2023 (the “Meeting”) in Toronto, Ontario. All matters presented to the shareholders of the Company (the “Shareholders”) for approval as set out in the Company’s Notice of Meeting and Information Circular, dated November 10, 2023 respectively, were approved by an overwhelming majority of votes cast at the Meeting. Of the 357,646,841 shares issued and outstanding on the record date for the Meeting, 143,297,862 shares, being 40% of the shares, were voted.
Shareholders of the Company re-elected Michael Frank, Joshua Herman, William L.C. Jackson, Andrew S. Lindzon and Christian Scovenna (the “Board of Directors”) for the ensuing year.
The Shareholders of the Company re-appointed Clearhouse LLP, Chartered Professional Accountants, as the Company’s auditors for the ensuing year, and authorized the Board of Directors to fix the remuneration to be paid to the auditors.
In addition, the Shareholders approved the Company’s 10% rolling stock option plan (the “Option Plan”), whereby the Company is authorized to issue options under the Option Plan to acquire up to 10% of the then issued and outstanding common shares in the capital of the Company at the time of grant.
Following the Meeting, the Board of Directors re-appointed Michael Frank as Executive Chairman and Chief Executive Officer, and Carmelo Marrelli as Chief Financial Officer and Corporate Secretary (the “Management”).
I'm holding on as well. I might as well go for broke on this one. But it seems to have life! GLTA
News out this morning. This is one of my favorite news releases. Hope to make some money back in 2024. Holding until I'm up or I die- whichever comes first is fine.
https://finance.yahoo.com/news/revive-therapeutics-collaborates-attwill-medical-120000498.html
So question for you guys. Ya know we used to pay TDR to pump our stock. Then it was eguityguru.com. Now we have this Trustunits guy. Do they come any cheaper?
I get having pre-game jitters before the AGM.
We all hope for greater stability and solid footing in Revive's process.
Desperate men do desperate things.
Should we be concerned for Snoopy?
Reading all the war, threat of war, saber rattling news going on, this is the perfect Bio-Tech plan right here right now. In fact, it may get rush funded by NATO allies.
https://www.msn.com/en-us/news/world/north-korea-threatens-war-declaration/ar-AA1kTwms?ocid=winp1taskbar&cvid=cbf3339869584179978d1a1173c483e4&ei=6
http://revivethera.com/2023/11/revive-therapeutics-provides-update-of-novel-bucillamine-formulation-development-2/
[img]http://img-s-msn-com.akamaized.net/tenant/amp/entityid/AA1kTwmp.img?w=534&h=353&m=6[img]
I see you are still dealing with those bashers. I've actually sold my position and took the loss, I then bought at 2 cents. I needed the loss anyway to counter some capital gains on other investments. I feel pretty good about buying back in at 2 cents.
Remember ~2 years ago reading about proposed research on LongCov using formulations of buccy but that was supposed to be done at USCF.
Lets see how this latest venture unfolds.
Thanks so much for yer invaluable input.
Now take utmost care that the door doesnt............. Eejit!!!
Thank you. I agree with every bit of it, but I think I would have worded it a little differently.
This is all BS all I hear finger crossed if we can get another pump and dump. Maybe we hit $1. In next three years. MF is just like his initials. He takes are money and we lose it to him. Nothing is going to get down. Stop inviting is this scam. Where is biotrader? And I here we got the data what a joke. One penny around the corner. Mary effing Christmas. Let it snow in MF pocket but not in are pockets. RS is next. The SEC goes after cryptocurrency companies but doesn't do anything for any scam stocks. Unless you're politician and got the inside which penny stock that are about to be pumped. For us retail investors it's like gambling on a roulette week with thousands of numbers to pick. It's all rigged all effing rigged. I should of taken my $20k to Vegas, at least I would have more fun with hookers and blow for a week not for three years of blue balls. Merry Christmas echo.
Good morning! Good things in the horizon….imho
3
Strong green upwards action. Interesting.
Sounds like the strategy used by Minerco investors.
Sounds like the strategy used by Minerco investors.
2 cents may be a good entry point for a short to intermediate term speculative play. One good, solid PR and this could be a quick 5-10 banger, even it the pop most likely would be short lived. Of course things could get worse, but downside risk at this point is rather small IMO. O/S size is still manageable, so there shouldn't be an R/S short-term. JMHO
This is exactly what I would have done. That has already made Liposomal Vitamin C, Photosomal Curcumin and Milk Thistle, Liposomal Co-Q10, and Liposomal L-Glutathione massive improvements in what they do for reducing body wide Inflammation and the problems they cause.
Some body in management knows what they are doing.
I always wonder why some want the share price at zero? Makes me wonder how many shares they are short
That is a lie based on the financials.
I believe we have been through this before, and this is likely a paid testimonial, but Revive is still alive.
https://equity.guru/video/revive-therapeutics-rvv-c-evolving-the-biopharmaceutical-landscape-with-innovative-therapies-and-strategic-partnerships/
Yes that is a bit excessive unless you have lots of money. lol
Einstein? Yep he is The Man. I agree with everything except the last sentence. A couple years ago on this very board, there was some bragging about 10 people owning 15 million shares. I can only speak for myself but that seems like way too many eggs in the basket to me. Yes this is a penny stock with no cash on hand. Anybody who forgets that is walking the plank. Keep playing the volatility.
Followers
|
337
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
36642
|
Created
|
02/23/17
|
Type
|
Free
|
Moderators Classic Warrior |
Scientific Rationale of Bucillamine
Preclinical and clinical studies have demonstrated that reactive oxygen species contribute to the destruction and programmed cell death of pulmonary epithelial cells.1 N-acetyl-cysteine (NAC) has been shown to significantly attenuate clinical symptoms in respiratory viral infections in animals and humans, primarily via donation of thiols to restore antioxidant and to reduce the activity of cellular glutathione 2,3,4,5. Bucillamine (N-(mercapto-2-methylpropionyl)-l-cysteine) has a well-known safety profile and is prescribed in the treatment of rheumatoid arthritis in Japan and South Korea for over 30 years. Bucillamine, a cysteine derivative with two thiol groups, has been shown to be 16 times more potent as a thiol donor in vivo than NAC 6. The drug is non-toxic with high cellular permeability. The basis of the clinical study will analyze if Bucillamine has the potential, via restoration of glutathione activity and other anti-inflammatory activity, to lessen the negative consequences of SARS-CoV2 infection in the lungs.
| Psilocin Pharma Corp. has developed production solutions for the active compound Psilocybin. Our process encompassed with our intellectual property cover methods of production of Psilocybin based formulations. Psilocin Pharma Corp’s range of products have been engineered to work synergistically with the body's own natural pathways of absorption while offering a contemporary approach to consumption. Psilocin Pharma also has strong relationships with specific lab partners in certain areas like Brazil, where these formulations are legally approved and plan to sell products in these jurisdictions. | |
| |
Mental Health (Depression, PTSD & Anxiety)
|
Supplements for Brain Health & Cognitive Enhancement
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |